Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Massacesi Cristian −$403K EVP,Chief Med Offr,Head of Dev sold 25% of stake
  2. Haller Julia A −$241K Director sold 11% of stake
  3. Holzer Phil M −$34K SVP and Controller sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-10 LEUNG SANDRA EVP, General Counsel Option exercise · Market Share Units −5,349 16,049
2023-03-10 LEUNG SANDRA EVP, General Counsel Grant or award · Market Share Units +21,663 21,663
2023-03-10 LEUNG SANDRA EVP, General Counsel Option exercise · Performance Shares −34,726 0
2023-03-10 LEUNG SANDRA EVP, General Counsel Grant or award · Performance Shares +32,494 32,494
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +4,189 25,481
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other acquisition +775 26,256
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,540 $65.71 $167K 23,716
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +4,885 28,601
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other acquisition +802 29,403
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,909 $65.71 $191K 26,494
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +4,765 31,259
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other acquisition +154 31,413
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,517 $65.71 $165K 28,896
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +25,139 54,035
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other acquisition +3,069 57,104
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −14,429 $65.71 $948K 42,675
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Market Share Units −4,189 4,192
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Market Share Units −4,885 9,771
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Market Share Units −4,765 14,297
2023-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Grant or award · Market Share Units +23,419 23,419

Page 46 of 56 · 1,112 trades